Medical Research News

RSS
SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Study finds increased oxidative stress, oxidant damage and glutathione deficiency in COVID-19 patients

Study finds increased oxidative stress, oxidant damage and glutathione deficiency in COVID-19 patients

Researchers identify a biomarker in platelets that tracks the extent of depression

Researchers identify a biomarker in platelets that tracks the extent of depression

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

Minimal nAb titers against Omicron in the elderly after 3rd dose

Minimal nAb titers against Omicron in the elderly after 3rd dose

Alzheimer’s disease risk genes disturb the brain protective mechanism

Alzheimer’s disease risk genes disturb the brain protective mechanism

Hypertension-related maternal mortality rates continue to increase in the United States

Hypertension-related maternal mortality rates continue to increase in the United States

SARS-CoV-2 Omicron study on hamsters, shows virus results in a less severe disease

SARS-CoV-2 Omicron study on hamsters, shows virus results in a less severe disease

Omicron surges in England especially in young

Omicron surges in England especially in young

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

Echinacea, a potent antiviral against SARS-CoV-2

Echinacea, a potent antiviral against SARS-CoV-2

Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

Study reveals how online misinformation 'ticks' and suggests new strategy to stop it

Study reveals how online misinformation 'ticks' and suggests new strategy to stop it

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

Engineer receives $2.1 million grant to test a treatment strategy for children with cerebral palsy

Engineer receives $2.1 million grant to test a treatment strategy for children with cerebral palsy

Study shows structural and functional aspects of antibody neutralization of SARS-CoV-2 Omicron variant

Study shows structural and functional aspects of antibody neutralization of SARS-CoV-2 Omicron variant

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

Less severe clinical consequences of infection with SARS-CoV-2 Omicron variant

Less severe clinical consequences of infection with SARS-CoV-2 Omicron variant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.